UC-San Francisco: Novel Immunotherapy Combination Destroys Colorectal Liver Metastases
October 08, 2025
October 08, 2025
SAN FRANCISCO, California, Oct. 8 (TNSjou) -- The University of California San Francisco campus issued the following news release:
* * *
Novel Immunotherapy Combination Destroys Colorectal Liver Metastases
UCSF researchers disrupt tumor immune environment with LIGHT/anti-CTLA-4 therapy in preclinical models.
*
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. . . .
* * *
Novel Immunotherapy Combination Destroys Colorectal Liver Metastases
UCSF researchers disrupt tumor immune environment with LIGHT/anti-CTLA-4 therapy in preclinical models.
*
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. . . .
